Henry Wolfe
18Patents
5h-index
26Co-inventors
66Inventor score
Filing activity: Dec 10, 1999 → Jan 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6424857B1 | Use of acousto-optical and sonoluminescene contrast agents | Human Necessities | 74 | Expired |
| US6548048B1 | Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6689871B1 | Process for production diphtheria toxin | Chemistry; Metallurgy | 35 | Expired |
| US9365608B2 | Method for treating diabetes | Chemistry; Metallurgy | 6 | Active |
| US8206704B2 | Use of GCC ligands | Human Necessities | 6 | Active |
| US9546194B2 | Aminosteroids for the treatment of a PTP1B associated disease | Chemistry; Metallurgy | 5 | Active |
| US7575891B2 | Process for production of diphtheria toxin | Chemistry; Metallurgy | 4 | Active |
| US7273728B2 | Process for production diphtheria toxin | Chemistry; Metallurgy | 4 | Expired |
| US6962803B2 | Process for production diphtheria toxin | Chemistry; Metallurgy | 3 | Expired |
| US7608242B2 | Peptide-chelate conjugates | Physics | 1 | Expired |
| US9492491B1 | Compositions and methods to inhibit kidney stone growth | Human Necessities | 1 | Active |
| US10471115B2 | Compositions and methods to inhibit kidney stone growth | Human Necessities | 0 | Active |
| US8748575B2 | Therapeutic peptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US11434257B2 | Aminosteroids for the treatment of a PTP1B associated disease | Chemistry; Metallurgy | 0 | Active |
| US9233135B1 | Compositions and methods to inhibit kidney stone growth | Human Necessities | 0 | Active |
| US9623066B2 | Compositions and methods to inhibit kidney stone growth | Human Necessities | 0 | Active |
| US10556923B2 | Aminosteroids for the treatment of a PTP1B associated disease | Chemistry; Metallurgy | 0 | Active |
| US9789152B2 | Compositions and methods to inhibit kidney stone growth | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.